Overall, these findings validate NrasG12D/PtenKO cancer cell-derived GM-CSF as a central regulatory cytokine promoting the differentiation and re-education of Ly6Clow myeloid cells with mixed immunosuppressive and proinflammatory/APC-like features. This evidence concerns the gene CSF2 and cancer.